References
- Gudlaugsson O, Gillespie S, Lee K, . Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 2003; 37: 1172–1177.
- Colombo A, Nucci M, Park BJ, . Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol 2006; 44: 2816–2823.
- Leroy O, Gangneux JP, Montravers P, . Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005–2006). Crit Care Med 2009; 37: 1612–1618.
- Wisplinghoff H, Bischoff T, Tallent SM, . Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309–317.
- Westermeyer C, Macreadie IG. Simvastatin reduces ergosterol levels, inhibits growth and causes loss of mtDNA in Candida glabrata. FEMS Yeast Res 2007; 7: 436–441.
- Forrest GN, Kopack A, Perencevich E. Statins in candidemia: clinical outcomes from a matched cohort study. BMC Infect Dis 2010; 10: 152–159.
- Liappis AP, Kan VL, Rochester C, Simon G. The effect of statins on mortality in patients with bacteremia. Clin Infect Dis 2001; 33: 1352–1357.
- Gupta R, Plantinga LC, Fink NE, . Statin use and hospitalization for sepsis in patients with chronic kidney disease. JAMA 2007; 297: 1455–1464.
- Dimopoulos G, Ntziora F, Rachiotis G, . Candida albicans versus non-C. albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcomes. Anesth Analg 2008; 106: 523–529.
- Viasus D, Gudiol C, Fernandez-Sabe N, . Effect of statins on outcomes in immunosuppressed patients with bloodstream infection. Eur J Clin Microbiol Infect Dis 2011; 30: 77–82.
- Macreadie IG, Johnson G, Schlosser T, . Growth inhibition of Candida species and Aspergillus fumigatus by statins. FEMS Microbiol Lett 2006; 262: 9–13.
- Wikhe K, Westermeyer C, Macreadie IG. Biological consequences of statins in Candida species and possible implications for human health. Biochem Soc Trans 2007; 35: 1529–1532.
- Kontoyiannis DP. Decrease in the number of reported cases of zygomycosis among patients with diabetes mellitus: a hypothesis. Clin Infect Dis 2007; 44: 1089–1090.
- Spanakis EK, Kourkoumpetis TK, Livanis G, . Statin therapy and decreased incidence of positive Candida cultures among patients with type 2 diabetes mellitus undergoing gastrointestinal surgery. Mayo Clin Proc 2010; 85: 1073–1079.